Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Assets:
Current assets:
Cash and cash equivalents
Cash
Accounts receivable
Advances to affiliate
Inventory - Millennium Cannabis
Millennium Cannabis
Millennium Produce
Total inventory - Millennium Cannabis
Prepaid legal fees
Other current assets
Current assets - held for sale
Current assets - discontinued operations
Total current assets
Property, plant and equipment, net
Millennium HI Carbon LLC
Millennium Carbon LLC (KY)
Walsenburg Cannabis LLC
Total property, plant and equipment, net
Other assets:
Security deposits
Right of use assets - Millennium Cannabis
Millennium HI Carbon LLC
Walsenburg Cannabis LLC
Millennium Cannabis
Millennium Produce
Millennium HI Carbon
Total right of use assets - Millennium Cannabis
Right of use assets - finance leases
Other assets - held for sale
Other assets - discontinued operations
Total assets
Liabilities and Shareholders’ Equity (Deficit)
Current liabilities:
Accounts payable and accrued expenses
Accounts payable - related party
Line of credit - related party, net of unamortized discount
Current portion of long-term debt
Lease liability - Millennium Cannabis
Millennium HI Carbon LLC
Walsenburg Cannabis LLC
Millennium Cannabis
Millennium Produce
Millennium HI Carbon
Total lease liability - Millennium Cannabis
Lease liability - finance leases
Current liabilities - held for sale
Current liabilities - discontinued operations
Total current liabilities
Long-term liabilities
Lease liability - Millennium Cannabis
Millennium HI Carbon LLC
Walsenburg Cannabis LLC
Millennium Cannabis
Millennium Produce
Millennium HI Carbon
Total lease liability - Millennium Cannabis
Lease liability - finance leases
Long-term debt
Long-term liabilities - held for sale
Long-term liabilities - discontinued operations
Total long-term liabilities
Total Liabilities
Common Stock; par value $0.0001 per share, 30,000,000 shares authorized, 10,999,814 shares issued and outstanding as of September 30, 2022 and 10,959,814 as of December 31, 2021
Paid-in capital
Accumulated Deficit
Total Equity (Deficit)
Total Liabilities and Equity (Deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support